TL;DR - What You Need to Know About FeelGood GLP-1 in 60 Seconds FeelGood GLP-1 is a telehealth platform connecting patients with licensed medical providers for evaluation and, when clinically appropriate, access to compounded GLP-1 injections starting at $149 per month - in a category where FDA formally proposed in April 2026 removing semaglutide and tirzepatide from the 503B outsourcing bulks list - with a public comment period open through June 2026
The episode exposed deep tensions between compounding pharmacies, branded pharmaceutical manufacturers, and federal regulators and raised fundamental questions about how far companies can push the boundaries of drug compounding law in the lucrative GLP-1 weight-loss market
Analysis of risk factors and development of a predictive model for new vertebral fractures subsequent to percutaneous kyphoplasty in patients with single-segment osteoporotic vertebral compression fractures Fumai Zhang, Jiayi Chen, Guang Li, Bin Wu, Wentao Cai BMC Musculoskeletal Disorders .2026;[Epub] CrossRef 2
Alcohols Role in Gastrointestinal Tract Disorders [online]
Additionally, Ozempic Has Been Found to Reduce the Risk of Major Cardiovascular Events, Offering Added Benefits for Heart Health